SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-001462
Filing Date
2021-01-11
Accepted
2021-01-11 16:33:40
Documents
2
Period of Report
2020-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea133115-8k_silopharma.htm 8-K 27426
2 SPONSORED RESEARCH AGREEMENT BY AND BETWEEN THE COMPANY AND THE UNIVERSITY OF MA ea133115ex10-1_silopharma.htm EX-10.1 129495
  Complete submission text file 0001213900-21-001462.txt   158373
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54872 | Film No.: 21521191
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl
Office of Manufacturing